LONDON, Feb. 18, 2021 /PRNewswire/ -- Hikma
Pharmaceuticals PLC (Hikma), the multinational pharmaceutical
company, announces it donated over $4
million USD in medicines in 2020 through its global medicine
donation program, continuing its long-running commitment to
supporting charities that address health issues in underserved
communities around the world.
Hikma also announces it has extended and increased donation
agreements with its existing partners, Dispensary of
Hope, Direct Relief and the National Children's
Cancer Society. Additionally, Hikma has established new
partnerships with Americares, a global health-focused relief
and development organisation that provides medicine, medical
supplies and health programs to people affected by poverty or
disaster; as well as Brother's Brother Foundation, which provides
essential healthcare, infrastructure, disaster response and
education resources to people in 42 countries.
"Hikma is committed to bringing better health to patients and
communities around the world," said Hana
Ramadan, Vice President, Corporate Social Responsibility.
"With the help of our partners throughout the past year, we have
increased our medicine donations to low-income groups, displaced
peoples and the uninsured -- all of whom faced increased challenges
due to the COVID-19 pandemic. By expanding our partnerships with
these vital charitable organisations, we will be able to provide
broader support for those most in need during this critical
time."
In 2020, Hikma donated $4.06
million in medicine, compared with $3.1 million in 2019. This included $1.1 million worth of medicines provided to the
Lebanese Ministry of Health immediately following the massive
explosion in Beirut this past
August. The company also offered assistance to those impacted
by the extreme floods that took place in Sudan in September
2020 by supporting 26,000 families with essential medicines
while providing 5,200 families with insecticides to protect against
the spread of mosquito-borne diseases. In the US, Hikma provided
more than 600,000 meals through its employee matching donation
campaign to pantries and food banks serving communities in the
company's New Jersey and
Ohio office locations.
Hikma US has formalised relationships and established new
partnerships with the following NGOs, including:
- Dispensary of Hope – Since 2017, Hikma has donated
more than 3 million doses (enough medications to fill over 100,000
prescriptions) to Dispensary of Hope, a charitable medication
distributor that collects and distributes millions of dollars of
pharmaceuticals annually to US pharmacies and safety-net clinics in
the US to dispense to low income, chronically ill patients.
- Direct Relief – Since 2018, Hikma has partnered
with Direct Relief, a humanitarian aid organisation, active in all
50 states and more than 80 countries, with a mission to improve the
health and lives of people affected by poverty or emergencies –
without regard to politics, religion or ability to pay. Hikma has
provided medicine donations to help various causes including the
Syrian Refugee Crisis, the 2019 Puerto Rico Earthquake, Hurricane
Dorian, US and Global COVID-19, the Beirut explosion and the US Safety Net Program
population.
- National Children's Cancer Society (NCCS) – Since
2017, Hikma has donated oncology medicines to NCCS, which helps
families navigating the daunting world of childhood cancer, from
financial to emotional support and much more. Hikma's donations
have been directed to numerous children's hospitals globally to
ensure children with cancer have access to the lifesaving medicines
they need.
- Americares and Brother's Brother Foundation
– Under its new partnerships with Americares and
Brother's Brother Foundation, Hikma will expand its reach and range
of donated medicines in the US and globally.
"With Hikma's help, we are able to distribute lifesaving cancer
drugs to paediatric oncology facilities we partner with. We're
thankful for Hikma's compassionate giving," explained Elizabeth Payne, Director, Michele Hertlein
Global Outreach Program for the National Children's Cancer
Society.
"Our partnership with Hikma expands the donated inventory of
primary care chronic illness and acute illness medications to serve
our nation's lowest income and uninsured friends, family and
neighbors," said Christopher
Palombo, Chief Executive Officer, Dispensary of Hope. "We
are especially appreciative of Hikma's continued support."
Inquiries
Hikma Pharmaceuticals
PLC
Steve
Weiss
US Communications and
Public Affairs
|
+1 732 788
8279
uscommunications@hikma.com
|
About Hikma
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC:
HKMPY) (rated BBB-/stable S&P, BBB-/stable Fitch and Ba1/stable
Moody's)
Hikma helps put better health within reach every day for
millions of people in more than 50 countries around the world. For
more than 40 years, we've been creating high-quality medicines and
making them accessible to the people who need them. Headquartered
in the UK, we are a global company with a local presence across
the United States (US), the
Middle East and North Africa (MENA) and Europe, and we use our unique insight and
expertise to transform cutting-edge science into innovative
solutions that transform people's lives. We're committed to our
customers, and the people they care for, and by thinking creatively
and acting practically, we provide them with a broad range of
branded and non-branded generic medicines. Together, our 8,600
colleagues are helping to shape a healthier world that enriches all
our communities. We are a leading licensing partner, and through
our venture capital arm, are helping bring innovative health
technologies to people around the world. For more information,
please visit: www.hikma.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/hikma-donates-over-4-million-usd-in-medicines-and-signs-new-long-term-partnerships-with-dispensary-of-hope-direct-relief-americares-brothers-brother-foundation-and-the-national-childrens-cancer-society-301230444.html
SOURCE Hikma Pharmaceuticals USA Inc.